The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Good long-term outcome of Budd-Chiari syndrome with a step-wise management
Abstract
Budd-Chiari syndrome (BCS) is a rare, life-threatening disease caused by obstruction of hepatic venous outflow. The aim of the study was to assess long-term outcome and identify prognostic factors in BCS patients managed by a step-wise approach using anticoagulation, angioplasty/thrombolysis, transjugular intrahepatic portosystemic shunting (TIPS), and orthotopic liver transplantation (OLT). We reviewed long-term data on 157 patients previously included by the European Network for Vascular Disorders of the Liver, a multicenter prospective study of newly diagnosed BCS patients in nine European countries. Patients were followed for a median of 50 months (range, 0.1-74.0). During the study, 88 patients (56%) received at least one invasive intervention (22 patients angioplasty/thrombolysis, 62 TIPS, and 20 OLT) and 36 (22.9%) died. Most interventions and/or deaths occurred in the first 2 years after diagnosis. The Rotterdam score was excellent in predicting intervention-free survival, and no other variable could significantly improve its prognostic ability. Moreover, BCS-TIPS prognostic index (PI) score (based on international normalized ratio, bilirubin, and age) was strongly associated with survival and had a discriminative capacity, which was superior to the Rotterdam score. Conclusions: The current study confirms, in a large cohort of patients with BCS recruited over a short period, that a step-wise treatment approach provides good long-term survival. In addition, the study validates the Rotterdam score for predicting intervention-free survival and the BCS-TIPS PI score for predicting survival. (Hepatology 2013;)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Malinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
Murad, S. D., Plessier, A., Hernandez-Guerra, M., Fabris, F., Eapen, C. E., Bahr, M. J., Trebicka, J., Morard, I., Lasser, L., Heller, J., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-3-200908040-00004 · Cited by 532
Self-citationBudd–Chiari syndrome: a review by an expert panel
Janssen, H. L. A., Garcia-Pagan, J.-C., Elias, E., Mentha, G., Hadengue, A., & Valla, D.-C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00434-8 · Cited by 491
Self-citationMurad, S. D., Valla, D.-C., de Groen, P. C., Zeitoun, G., Hopmans, J. A. M., Haagsma, E. B., van Hoek, B., Hansen, B. E., Rosendaal, F. R., & Janssen, H. L. A. (2004) · Hepatology · doi:10.1002/hep.20064 · Cited by 357
Self-citationTIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients
Garcia–Pagán, J. C., Heydtmann, M., Raffa, S., Plessier, A., Murad, S., Fabris, F., Vizzini, G., Abraldes, J. G., Olliff, S., Nicolini, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.051 · Cited by 354
Self-citationAiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
Plessier, A., Sibert, A., Consigny, Y., Hakimé, A., Zappa, M., Denninger, M., Condat, B., Farges, O., Chagneau, C., de Lédinghen, V., et al. (2006) · Hepatology · doi:10.1002/hep.21354 · Cited by 292
Self-citationZeitoun, G., Escolano, S., Hadengue, A., Azar, N., El Younsi, M., Mallet, A., Boudet, M.-J., Hay, J.-M., Erlinger, S., Benhamou, J.-P., et al. (1999) · Hepatology · doi:10.1002/hep.510300125 · Cited by 242
Self-citationThe changing scene of hepatic vein thrombosis: Recognition of asymptomatic cases
Hadengue, A., Poliquin, M., Vilgrain, V., Belghiti, J., Degott, C., Erlinger, S., & Benhamou, J.-P. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90765-x · Cited by 228
Self-citationLUDWIG, J., HASHIMOTO, E., McGILL, D. B., & van HEERDEN, J. A. (1990) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62109-0 · Cited by 223
Clinicopathological forms and prognostic index in Budd-Chiari syndrome
Langlet, P., Escolano, S., Valla, D., Coste-Zeitoun, D., Denie, C., Mallet, A., Levy, V.-G., Franco, D., Vinel, J.-P., Belghiti, J., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00323-4 · Cited by 180
Self-citationHepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West
VALLA, D. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03642.x · Cited by 159
Self-citationTreatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation
Hemming, A. W., Langer, B., Greig, P. D., Taylor, B., Adams, R. B., & Heathcote, E. J. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80095-6 · Cited by 117
Panis, Y. H., Belghiti, J., Valla, D. C., Benhamou, J. P., & FEKETE, F. (1994) · PubMed · Cited by 101
Self-citationLong-term portosystemic shunt patency as a determinant of outcome in Budd–Chiari syndrome
Bachet, J., Condat, B., Hagège, H., Plessier, A., Consigny, Y., Belghiti, J., & Valla, D. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.016 · Cited by 67
Self-citationIs surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome?
Langlet, P., & Valla, D. C. (2002) · PubMed · Cited by 39
Self-citation
Cited by
EASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
Self-citationTransjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
Tripathi, D., Stanley, A. J., Hayes, P. C., Travis, S., Armstrong, M. J., Tsochatzis, E. A., Rowe, I. A., Roslund, N., Ireland, H., Lomax, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320221 · Cited by 314
Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts
Dariushnia, S. R., Haskal, Z. J., Midia, M., Martin, L. G., Walker, T. G., Kalva, S. P., Clark, T. W. I., Ganguli, S., Krishnamurthy, V., Saiter, C. K., et al. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2015.09.018 · Cited by 271
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
Candeloro, M., Valeriani, E., Monreal, M., Ageno, W., Riva, N., Lopez-Reyes, R., Peris, M. L., Beyer Westendorf, J., Schulman, S., Rosa, V., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007961 · Cited by 36
Metadata
- Authors
- Seijo, S., Plessier, A., Hoekstra, J., Dell'Era, A., Mandair, D., Rifai, K., Trebicka, J., Morard, I., Lasser, L., Abraldes, J. G., Darwish Murad, S., Heller, J., Hadengue, A., Primignani, M., Elias, E., Janssen, H. L. A., Valla, D. C., & Garcia-Pagan, J.-C.
- Venue
- Hepatology
- Published
- 2013-05
- Volume
- 57
- Issue
- 5
- Pages
- 1962-1968
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2030293340
- Cited by
- 305
- References
- 16
- FWCI
- 14.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.